Compare GSK plc (GSK) vs Ralph Lauren Corp (RL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Ralph Lauren Corp — how do they compare? GSK plc trades at $50.55 (market cap $102.60B), while Ralph Lauren Corp trades at $397.75 (market cap $23.70B). The key difference: GSK plc is far larger — about 4.3× Ralph Lauren Corp's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | RL | |
|---|---|---|
Market Cap | $102.60B | $23.70B |
Sector | Health | Consumer Cyclical |
52-Week High | $61.18 | $414.25 |
52-Week Low | $38.22 | $285.35 |
Enterprise Value | $123.04B | $24.76B |
Dividend Yield | 3.57% | 0.94% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →
